Growth Metrics

TriSalus Life Sciences (TLSI) Depreciation & Amortization (CF) (2022 - 2026)

TriSalus Life Sciences has reported Depreciation & Amortization (CF) over the past 5 years, most recently at $135000.0 for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) fell 21.51% year-over-year to $135000.0; the TTM value through Mar 2026 reached $589000.0, down 20.51%, while the annual FY2025 figure was $626000.0, 15.86% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $135000.0 at TriSalus Life Sciences, up from $126000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $194000.0 in Q4 2023 and troughed at -$54000.0 in Q4 2022.
  • A 5-year average of $152500.0 and a median of $168500.0 in 2025 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 459.26% in 2023 and later crashed 34.72% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at -$54000.0 in 2022, then surged by 459.26% to $194000.0 in 2023, then dropped by 0.52% to $193000.0 in 2024, then crashed by 34.72% to $126000.0 in 2025, then increased by 7.14% to $135000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for TLSI at $135000.0 in Q1 2026, $126000.0 in Q4 2025, and $163000.0 in Q3 2025.